2018
DOI: 10.3390/nano8040195
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, Self-Assembly, and Drug-Release Properties of New Amphipathic Liquid Crystal Polycarbonates

Abstract: New amphiphilic liquid crystal (LC) polycarbonate block copolymers containing side-chain cholesteryl units were synthesized. Their structure, thermal stability, and LC phase behavior were characterized with Fourier transform infrared (FT-IR) spectrum, 1H NMR, gel permeation chromatographic (GPC), thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), polarizing optical microscope (POM), and XRD methods. The results demonstrated that the LC copolymers showed a double molecular arrangement of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 43 publications
0
4
0
Order By: Relevance
“…However, the main limitation of PCL is its relatively slow bioresorption rate in vivo [37, 43]. Moreover, the products of PCL degradation are acidic and could cause delayed aseptic inflammatory response when implanted in vivo, resulting in failure of implantation [44, 45]. The purpose of the present study is to improve the mechanical properties and degradation properties of PCL materials by B-BG composite with the contents of 0, 10, 20, 30, and 40 wt.%, respectively.…”
Section: Discussionmentioning
confidence: 99%
“…However, the main limitation of PCL is its relatively slow bioresorption rate in vivo [37, 43]. Moreover, the products of PCL degradation are acidic and could cause delayed aseptic inflammatory response when implanted in vivo, resulting in failure of implantation [44, 45]. The purpose of the present study is to improve the mechanical properties and degradation properties of PCL materials by B-BG composite with the contents of 0, 10, 20, 30, and 40 wt.%, respectively.…”
Section: Discussionmentioning
confidence: 99%
“…Literature from the last ten years contains many examples of drug carriers prepared from polycarbonates and polycarbonate-containing copolymers [ 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 ].…”
Section: Polymers For Preparation Of Drug Delivery Carriersmentioning
confidence: 99%
“…The copolymers listed in Table 1 were used for preparation of functional nanoparticles by nanoprecipitation [ 39 , 76 , 80 , 81 , 171 , 174 , 207 , 210 ], reverse nanoprecipitation [ 78 , 79 , 167 , 169 , 179 , 209 , 211 ], solvent evaporation/dialysis [ 60 , 61 , 63 , 64 , 66 , 70 , 71 , 72 , 73 , 74 , 75 , 168 , 170 , 171 , 172 , 178 , 184 , 185 , 194 ], salting-out [ 189 ], freeze-drying [ 180 , 186 ], electrospraying [ 192 , 206 ], heat-denaturation [ 190 , 196 , 198 ], and ionic gelation [ 197 ]. The nanoparticles were loaded with doxorubicin [ 60 , 64 , 66 , 71 , 72 , 74 ,…”
Section: Preparation Of Functionalized Nano- and Microparticlesmentioning
confidence: 99%
“…Moreover, computer-aided design has been rapidly developed in order to optimize OC scaffolds with reduced design period and experimental cost. In view of processability, flexibility and cost-effectiveness, polymer-based biomaterials with good biodegradability and biocompatibility [18] have drawn our attention, particularly polymer-based nanocomposites due to the presence of inorganic nHA crystals in bone.…”
Section: Introductionmentioning
confidence: 99%